reverse phase protein array
Working within I-SPY 2, the researchers identified a signature for determining whether patients are better candidates for anti-HER2 or immune checkpoint therapies.
Diverse Alterations Detected In Rare, Aggressive Uterine Cancer
An integrated analysis of uterine carcinosarcomas uncovered a range of somatic mutations and shifts in transcription, methylation, and microRNA expression.
Phosphoproteomic Data from I-SPY 2 IDs Potential New Marker of Patient Response to Neratinib
Premium
The marker has the potential to improve upon existing markers like HER2 and HR status while also expanding the population of patients considered for neratinib treatment.
MD Anderson's Mills Building Cancer Proteome Atlas Using RPPA Data from 70,000-plus Patient Samples
Premium
Led by Gordon Mills, chair of systems biology at the University of Texas MD Anderson Cancer Center, a group of researchers is developing a database containing proteomic characterizations of thousands of cancer patient samples and cell lines.
GMU Team Builds Phosphoproteomic-based Pathway Activation Profiles of NCI-60 Cancer Cell Lines
Premium
A team led by researchers at George Mason University has completed a phosphoproteomic analysis of the National Cancer Institute-60, a set of 60 human cancer cell lines.
Sep 14, 2012
Aug 31, 2012
Apr 6, 2012
Nov 12, 2010
Aug 14, 2010